We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.24B
AUM Growth
-$83.1M
Cap. Flow
-$36.7M
Cap. Flow %
-2.97%
Top 10 Hldgs %
21.29%
Holding
139
New
26
Increased
28
Reduced
58
Closed
12

Top Buys

Rank Stock Value
1
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$22.9M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$21.8M
3
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
+$20.3M
4
AVAH icon
Aveanna Healthcare
AVAH
+$19.7M
5
INSM icon
Insmed
INSM
+$16.1M

Top Sells

Rank Stock Value
1
PPD
PPD, Inc. Common Stock
PPD
+$32.3M
2
AVIR icon
Atea Pharmaceuticals
AVIR
+$24M
3
NVAX icon
Novavax
NVAX
+$18.8M
4
ARVN icon
Arvinas
ARVN
+$13M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 94.02%
2 Industrials 4.68%
3 Financials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
101
Regeneron Pharmaceuticals
REGN
$72.9B
$2.36M 0.19%
4,220
-400
-9% -$203K
LATN
102
DELISTED
Union Acquisition Corp. II Ordinary Shares
LATN
$2.17M 0.18%
+215,582
New +$2.17M
ONC
103
BeOne Medicines Ltd
ONC
$33.9B
$2.06M 0.17%
6,000
+200
+3% +$66.2K
CYRX icon
104
CryoPort
CYRX
$753M
$2.03M 0.16%
32,234
-34,800
-52% -$1.96M
GILD icon
105
Gilead Sciences
GILD
$165B
$2.01M 0.16%
29,250
– –
VRTX icon
106
Vertex Pharmaceuticals
VRTX
$123B
$1.96M 0.16%
9,721
-1,600
-14% -$335K
ILMN icon
107
Illumina
ILMN
$29.5B
$1.87M 0.15%
4,071
-205
-5% -$82.6K
CTSO icon
108
Cytosorbents Corp
CTSO
$22.2M
$1.85M 0.15%
244,660
-28,000
-10% -$236K
ZLAB icon
109
Zai Lab
ZLAB
$2.07B
$1.04M 0.08%
5,900
– –
IQV icon
110
IQVIA
IQV
$40.7B
$727K 0.06%
+3,000
New +$693K
INCY icon
111
Incyte
INCY
$25.8B
$691K 0.06%
8,210
– –
KLRS
112
Kalaris Therapeutics
KLRS
$80.9M
$690K 0.06%
1,520
+587
+63% +$303K
ARGX icon
113
argenx
ARGX
$55.2B
$563K 0.05%
1,870
– –
CRSP icon
114
CRISPR Therapeutics
CRSP
$4.69B
$529K 0.04%
3,270
– –
RDY icon
115
Dr. Reddy's Laboratories
RDY
$9.8B
$474K 0.04%
32,270
– –
ASND icon
116
Ascendis Pharma A/S
ASND
$16.5B
$467K 0.04%
3,550
+300
+9% +$40K
GBIO
117
DELISTED
Generation Bio
GBIO
$444K 0.04%
1,652
-500
-23% -$150K
MRTX
118
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$393K 0.03%
2,431
-76,650
-97% -$12.3M
AFMD
119
DELISTED
Affimed
AFMD
$383K 0.03%
+4,500
New +$411K
LITS
120
Lite Strategy Inc
LITS
$32.4M
$368K 0.03%
6,449
-91,634
-93% -$5.88M
ALGS icon
121
Aligos Therapeutics
ALGS
$26.3M
$345K 0.03%
676
-72
-10% -$45.9K
TIL icon
122
Instil Bio
TIL
$49M
$326K 0.03%
844
-18,019
-96% -$6.68M
LEGN icon
123
Legend Biotech
LEGN
$3.65B
$304K 0.02%
7,400
-2,900
-28% -$98.6K
RAIN
124
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$282K 0.02%
+18,155
New +$318K
COGT icon
125
Cogent Biosciences
COGT
$6.76B
$219K 0.02%
27,000
– –
2 3 4
5
6

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Sectoral Asset Management held 139 positions worth $1.24B, down 6.3% from $1.32B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Sectoral Asset Management's Q2 2021 filing shows 26 new, 28 increased, 58 reduced and 12 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 271,206 shares worth $24.3M. The largest sale was PPD, Inc. Common Stock, an estimated $32.3M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 94% a quarter earlier, followed by Industrials and Financials.

  • Sectoral Asset Management's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 271,206 shares worth $24.3M.
  • Sectoral Asset Management added most to Insmed in Q2 2021, an estimated $16.1M increase.
  • Sectoral Asset Management's biggest Q2 2021 reduction was Atea Pharmaceuticals, cutting an estimated $24M.
  • Sectoral Asset Management fully exited PPD, Inc. Common Stock in Q2 2021, selling an estimated $32.3M.
  • Sectoral Asset Management's ten largest holdings make up 21% of its $1.24B portfolio in Q2 2021.
  • Sectoral Asset Management opened 26 new positions and closed 12 in Q2 2021.
  • Sectoral Asset Management's portfolio value fell 6.3% quarter-over-quarter to $1.24B.

Based on Sectoral Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.